Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Frequency of Zoledronic Acid to Prevent Further Bone Loss in Osteoporotic Patients Requiring Androgen Deprivation Therapy for Prostate Cancer

NCT00520052 is registered in ClinicalTrials.gov with Wirral University Teaching Hospital NHS Trust as lead sponsor.

NCT NCT00520052
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00520052 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Frequency of Zoledronic Acid to Prevent Further Bone Loss in Osteoporotic Patients Requiring Androgen Deprivation Therapy for Prostate Cancer
Lead sponsor
Wirral University Teaching Hospital NHS Trust
Phase
Not applicable
Overall status
Completed
Start date
August 31, 2003
Completion date
August 31, 2005
Enrollment
58 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

osteoporosis